Frequency of primary clinical manifestations of bleeding diseases in patients referred to Besat Hospital in Hamadanin 2020-2021

Salimi, R.; Zolfaghari, B.; Isfahani, H.; Rafieemehr, H.

References:

Iorio A, Stonebraker JS, Chambost H, Makris M, Coffin D, Herr C, et al. Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries. Ann Intern Med 2019; 171(8): 540-6.
Rafieemehr H, Dorgalaleh A, Mansouritorghabeh H. Mining of mortality-related findings in rare bleeding disorders: a retrospective study from two centers. Blood Res 2020; 55(4): 213-6.
Smith SA, Travers RJ, Morrissey JH. How it all starts: Initiation of the clotting cascade. Crit Rev Biochem Mol Biol 2015; 50(4): 326-36.
Hosseini F, Jolayi H, Valizadeh L, Tabaghchy Ahary A, Hashemi M, Varmazyar Z. The knowledge of hemophilia affected adolescents on the prevention of hemophilia complications. Sci J Iran Blood Transfu Organ 2014; 10(4): 372-86. [Article in Farsi]
Rafieemehr H, Lorestani rad ّ, Majidi L, Jahangiri A. The ratio of cross-matched blood to transfusion in trauma patients receiving blood in the emergency department of Besat hospital in Hamadan in 2020. Sci J Iran Blood Transfus Organ 2021; 18(3): 196-204. [Article in Farsi]
Rogers GL, Herzog RW. Gene therapy for hemophilia. Front Biosci (Landmark Ed) 2015; 20: 556-63.
Abshire T. The role of prophylaxis in the management of von Willebrand disease: today and tomorrow. Thromb Res 2009; 124: S15-S9.
Chambost H. Assessing risk factors: prevention of inhibitors in haemophilia. Haemophilia 2010; 16: 10-5.
Ivanciu L, Toso R, Margaritis P, Pavani G, Kim H, Schlachterman A, et al. A zymogen-like factor Xa variant corrects the coagulation defect in hemophilia. Nat Biotechnol 2011; 29(11): 1028-33.
Luck Jr JV, Silva M, Rodriguez-Merchan CE, Ghalambor N, Zahiri CA, Finn RS. Hemophilic arthropathy. J Am Acad Orthop Surg 2004; 12(4): 234-45.
Ferreira AA, Leite ICGa, Bustamante-Teixeira MT, Corrأھa CSL, Cruz DTd, Rodrigues DdOW, et al. Health-related quality of life in hemophilia: results of the Hemophilia-Specific Quality of Life Index (Haem-a-Qol) at a Brazilian blood center. Rev Bras Hematol Hemoter 2013; 35: 314-8.
Nilsson IM, Hedner U, Ahlberg A. Haemophilia prophylaxis in Sweden. Acta Paediatr Scand 1976; 65(2): 129-35.
Fatehifar M, Horfar H, Akbari N, Eshraghi M, Hojatifar M, Motamedi N, et al. The correlation of factor VIII and von Willebrand levels with clinical symptoms in obligate carriers of hemophilia A in Isfahan. Sci J Iran Blood Transfu Organ 2014; 11(2): 110-5. [Article in Farsi]
Street A, Ljung R, Lavery S. Management of carriers and babies with haemophilia. Haemophilia 2008; 14 Suppl 3: 181-7.
Karimi S, Javadi M, Jafarzadeh F. Economic Burden and Costs of Chronic Diseases in Iran and the World. Health Information Management 2012; 8(7): 996. [Article in Farsi]
Salimi R, Zarei O, Rafieemehr H. Evaluation of blood consumption pattern and its relation with causes of mortality in ward of general ICU of Besat educational medical center of Hamadan in 2018-2019. Sci J Iran Blood Transfus Organ 2020; 17(3): 179-87. [Article in Farsi]
Mansouritorgabeh H, Rezaieyazdi Z, Pourfathollah A, Rezai J, Esamaili H. Haemorrhagic symptoms in patients with combined factors V and VIII deficiency in north-eastern Iran. Haemophilia 2004; 10(3): 271-5.
Naderi M, Imani M, Eshghi P, Dorgalaleh A, Tabibian S, Alizadeh S, et al. Factor XIII deficiency in Sistan and Baluchistan province. Sci J Iran Blood Transfus Organ 2013; 10(3): 282-8. [Article in Farsi]
Sherief L, Mansour A. Epidemiological profile of Inherited Bleeding Disorders in Egyptian Pediatric Patients: 4 Centers Experience, Retrospective Analysis. Annals of the Romanian Society for Cell Biology 2021; 25(6): 14152-65.
Martenez-Sanchez LM, Cardona-Velez J, Ramirez-Pulgarin S, Rodriguez-Gezquez M. Clinical and epidemiological profile of patients with hemophilia in Liga de Hemofilicos de Antioquia (Colombia). Revista Medica de Risaralda 2017; 23(1): 34-7.
Mansouritorghabeh H, Manavifar L, Banihashem A, Modaresi A, Shirdel A, Shahroudian M, et al. An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran. Blood Transfus 2013; 11(2): 233.
Farjami A, Haghpanah S, Arasteh P, Ardeshiri R, Tavoosi H, Zahedi Z, et al. Epidemiology of hereditary coagulation bleeding disorders: a 15-year experience from Southern Iran. Hospital Practices and Research 2017; 2(4): 113-7.
Pour-Jafari H, Hashemzadeh Chaleshtori M. Different Types of the Coagulation Disorders in Hamadan and A Comparison of the ABO & Rh Blood Group Distribution in the Patients and the Control Group. Avicenna Journal of Clinical Medicine 2003; 10(3): 51-4.
Kashefi P, Abbasi S, Alikiaii B, Kouhi H. Prevalence of Coagulopathy and Related Risk factors in Patients with Trauma Hospitalized in Intensive Care Units of Alzahra Hospital, Isfahan, Iran, during 2013-2016. J Isfahan Med School 2017; 35(447): 1256-62. [Article in Farsi]
Kadhim K, Lami F. Prevalence and Seroconversion of Viral Hepatitis B and C and HIV Among Hemophilia Patients in Baghdad, Iraq, 2016. Iproceedings. 2016; 4(1): e10612.
Keikhayi B, Hosseini Nik2, Morteza. The Evaluation of the Relationship between Plasma Levels of Factor VIII with Bleeding Symptoms in Hemophilia a Carriers Referring to Shafa Hospital of Ahvaz, Iran. Jundishapur Scientific Medical Journal. 2017; 16(3): 326-32. [Article in Farsi]
Catelli DH, Portich JlP, Luz AC, da Costa Diaz GF, de Ourique LO, Hoffmann DS, et al. Epidemiological characteristics of hemophilia in the pre-primary prophylaxis era: a historical cohort. Clinical & Biomedical Research 2021; 41(1): 1-5.

Sci J Iran Blood Transfus Organ 2022;19 (2): 122-130

Original Article

Frequency of primary clinical manifestations of bleeding
diseases in patients referred to Besat Hospital in Hamadan
in 2020-2021

Salimi R.¹, Zolfaghari B.¹, Isfahani H.¹, Rafieemehr H.²

¹School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
²School of Paramedicine, Hamadan University of Medical Sciences, Hamadan, Iran

Abstract
Background and Objectives
The clinical manifestations of bleeding diseases is very important in terms of proper management and prevention strategies. The aim of this study was to determine the frequency of early clinical manifestations of bleeding diseases in Hamadan.

Materials and Methods
In this cross-sectional study, 76 patients with hemorrhagic diseases with medical records in Besat Hospital during 2020-2021 in terms of age, sex, type of hemorrhagic disease, the primary clinical manifestations, coagulation factor level, family history of hemophilia, number of blood product injections, receiving way of blood products and illness severity were evaluated. Data were analyzed using chi-square test and SPSS software version 23.

Results
The mean age of patients was 24.60 ± 15.56 years; 82.92% were male and 17.08% were female. Hematoma (18.42%), petechiae and ecchymosis (18.42%), bleeding after circumcision (18.42%), and nosebleeds(10.50%) were the most common initial manifestations. Hemophilia type A with 67.1% which was severe (66.77%), moderate (14.4%) and mild (18.83%). No significant difference between the severity of hemophilia with the initial manifestations of the disease and the type of product was observed and neither between girls and boys in terms of initial clinical manifestations.

Conclusions
In this study, the most common BDs in hemophilia occurred within the ages of 1-2 years with Glanzman syndrome the most frequent. Hematoma, petechiae, ecchymosis, and bleeding were the most common occurrences in hemophiliacs. Most of them had a severe form of the disease and in terms of type, severity, and first clinical manifestations of hemophilia the findings were almost similar to the results of other studies.

Key words: Hemophilia A, Hospitals, Bleeding

Received: 29 Dec 2021
Accepted: 12 Mar 2022

Correspondence: Rafieemehr H., PhD of Hematolgy & Blood Banking. Associated professor of School of Paramedicine, Hamadan University of Medical Sciences.
Postal Code: 6517838736, Hamadan, Iran. Tel: (+98811) 8276295; Fax: (+98811) 8281442
E-mail: rafee_1352@yahoo.com